June 02, 2015
University of Pittsburgh Bioengineering Professor and ERC-RMB thrust leader Prashant Kumta presented progress in biodegradable implants developed by 3D printing technology in Science& Technology news article "Scientists Develop Biodegradable Parts to Fix Fractures" published in "Voice of America":
October 5, 2015
Source: Fierce Medical Devices
Boston Scientific's Synergy stent--Courtesy of Boston Scientific
The FDA just approved its first third-generation bioabsorbable stent, to the delight of Boston Scientific ($BSX).
The company's Synergy Bioabsorbable Polymer Drug-Eluting Stent System is supposed to improve long-term outcomes because its polymer coating starts to get absorbed by the body following the completion of the elution of the drug everolimus, which takes three months.
The Synergy is considered a partially bioabsorbable stent because the devices' platinum chromium body and stent struts do not dissolve away from within the coronary artery. Abbott's ($ABT) Absorb BVS is on track to become the first fully bioabsorbable (also referred to as bioresorbable) stent to gain FDA approval.
Link: Boston Scientific Press Release
January 14, 2015
ERC-RMB’s progress examining histology of bioresorbable implants with it’s Industrial member nanoMAG, which was featured in Dec 2014 Chemical Engineering Progress. This article was prepared by the National Science Foundation in partnership with CEP:
CEP, December 2014, p.14 (249 kb)
Reprinted from Chemical Engineering Progress (CEP) with permission of the American Institute of Chemical Engineers (AIChE, http://aiche.org/cep).
2013-2014 Translational research initiatives include the following:
- Revisions to the Membership Agreement
- Industrial Engagement
- ERC Technology Transfer
Hannover, 4 September, 2013. A global medical innovation from Hannover: Syntellix AG has managed to get a metal implant that is degraded by the body approved for regular use in 30 countries. Syntellix is thus the only enterprise whose product of this kind has been approved on such a level. This information was publically released by the company on Wednesday in Hannover in the presence of Stephan Weil, Prime Minister of Lower Saxony.
Press-release from Syntellix